Autoimmunity in microbiome-mediated diseases and novel therapeutic approaches

Cheolmin Shin, Yong Ku Kim

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The microbiome mediates constant bidirectional communication with the host immune system in a delicate balance of inducing pathogenic infection or residing in the human body in a commensal state. Dysbiosis is a hallmark of several autoimmune and immune-mediated inflammatory diseases. Various pathways involved in microbiome-induced autoimmunity are activated when a genetic defect or microbial trigger is found in the inflammasome, neutrophil extracellular trap, or receptors for microbial sensitization in the innate immune system or when similar defects are present in T or B lymphocytes of the adaptive immune system. Regulating autoimmunity through microbiome modulation may be highly effective as a therapeutic intervention.

Original languageEnglish
Pages (from-to)34-42
Number of pages9
JournalCurrent Opinion in Pharmacology
Volume49
DOIs
Publication statusPublished - 2019 Dec 1

Fingerprint

Microbiota
Autoimmunity
Immune System
Dysbiosis
Inflammasomes
Human Body
B-Lymphocytes
Therapeutics
T-Lymphocytes
Infection

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Autoimmunity in microbiome-mediated diseases and novel therapeutic approaches. / Shin, Cheolmin; Kim, Yong Ku.

In: Current Opinion in Pharmacology, Vol. 49, 01.12.2019, p. 34-42.

Research output: Contribution to journalReview article

@article{7dd855e3644b460b90f84ce2c86ef3ba,
title = "Autoimmunity in microbiome-mediated diseases and novel therapeutic approaches",
abstract = "The microbiome mediates constant bidirectional communication with the host immune system in a delicate balance of inducing pathogenic infection or residing in the human body in a commensal state. Dysbiosis is a hallmark of several autoimmune and immune-mediated inflammatory diseases. Various pathways involved in microbiome-induced autoimmunity are activated when a genetic defect or microbial trigger is found in the inflammasome, neutrophil extracellular trap, or receptors for microbial sensitization in the innate immune system or when similar defects are present in T or B lymphocytes of the adaptive immune system. Regulating autoimmunity through microbiome modulation may be highly effective as a therapeutic intervention.",
author = "Cheolmin Shin and Kim, {Yong Ku}",
year = "2019",
month = "12",
day = "1",
doi = "10.1016/j.coph.2019.04.018",
language = "English",
volume = "49",
pages = "34--42",
journal = "Current Opinion in Pharmacology",
issn = "1471-4892",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Autoimmunity in microbiome-mediated diseases and novel therapeutic approaches

AU - Shin, Cheolmin

AU - Kim, Yong Ku

PY - 2019/12/1

Y1 - 2019/12/1

N2 - The microbiome mediates constant bidirectional communication with the host immune system in a delicate balance of inducing pathogenic infection or residing in the human body in a commensal state. Dysbiosis is a hallmark of several autoimmune and immune-mediated inflammatory diseases. Various pathways involved in microbiome-induced autoimmunity are activated when a genetic defect or microbial trigger is found in the inflammasome, neutrophil extracellular trap, or receptors for microbial sensitization in the innate immune system or when similar defects are present in T or B lymphocytes of the adaptive immune system. Regulating autoimmunity through microbiome modulation may be highly effective as a therapeutic intervention.

AB - The microbiome mediates constant bidirectional communication with the host immune system in a delicate balance of inducing pathogenic infection or residing in the human body in a commensal state. Dysbiosis is a hallmark of several autoimmune and immune-mediated inflammatory diseases. Various pathways involved in microbiome-induced autoimmunity are activated when a genetic defect or microbial trigger is found in the inflammasome, neutrophil extracellular trap, or receptors for microbial sensitization in the innate immune system or when similar defects are present in T or B lymphocytes of the adaptive immune system. Regulating autoimmunity through microbiome modulation may be highly effective as a therapeutic intervention.

UR - http://www.scopus.com/inward/record.url?scp=85065859725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065859725&partnerID=8YFLogxK

U2 - 10.1016/j.coph.2019.04.018

DO - 10.1016/j.coph.2019.04.018

M3 - Review article

C2 - 31129556

AN - SCOPUS:85065859725

VL - 49

SP - 34

EP - 42

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

SN - 1471-4892

ER -